The estimated Net Worth of Technology Ventures Vii Lp ... is at least $53.2 millier dollars as of 20 June 2005. Technology Lp owns over 1,277,373 units of Cortexyme Inc stock worth over $53,186 and over the last 19 years Technology sold CRTX stock worth over $0.
Technology has made over 1 trades of the Cortexyme Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Technology bought 1,277,373 units of CRTX stock worth $7,000,004 on 20 June 2005.
The largest trade Technology's ever made was buying 1,277,373 units of Cortexyme Inc stock on 20 June 2005 worth over $7,000,004. On average, Technology trades about 1,277,373 units every 0 days since 2005. As of 20 June 2005 Technology still owns at least 27,275 units of Cortexyme Inc stock.
You can see the complete history of Technology Lp stock trades at the bottom of the page.
Over the last 21 years, insiders at Cortexyme Inc have traded over $59,595,534 worth of Cortexyme Inc stock and bought 19,273,711 units worth $164,053,955 . The most active insiders traders include & Johnson Johnson & Johnson..., Farmaceutici Sp A Chiesi et Ansbert Gadicke. On average, Cortexyme Inc executives and independent directors trade stock every 59 days with the average trade being worth of $475,426. The most recent stock trade was executed by Caryn Gordon Mc Dowell on 6 June 2022, trading 10,800 units of CRTX stock currently worth $30,888.
Cortexyme, Inc. is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer's and other degenerative diseases. Based upon the evidence generated to date, Cortexyme is currently advancing its lead therapeutic candidate, atuzaginstat (COR388), in the GAIN Trial, an ongoing Phase 2/3 clinical trial in patients with mild to moderate Alzheimer's disease. Cortexyme is targeting a specific, infectious pathogen found in the brain and other organs and tied to degeneration and inflammation in humans and animal models.
Cortexyme Inc executives and other stock owners filed with the SEC include: